Latest Articles
- Digoxin is still useful, but is still causing toxicity
The authors review the presentation of digoxin toxicity, its mechanisms and predisposing factors, and its medical management.
- Diabetic retinopathy: Screening, prevention, and treatment
Effective screening processes, timely referrals, and strategic diabetes management are essential to prevent and mitigate the consequences of diabetic retinopathy.
- Persistent erosions of the glans penis and foreskin
A 66-year-old man presented with an 8-month history of persistent erosions of the glans penis and foreskin with slight itching and pain.
- Lymphedema vs lipedema: Similar but different
Lymphedema, lipedema, and even simple obesity in the extremities can resemble each other superficially and are often confused for one another, but they differ in important ways.
- Do patients with sepsis benefit from intravenous albumin?
Patients with sepsis who do not need vasopressors do not benefit from intravenous albumin compared with intravenous crystalloid therapy alone.
- SGLT-2 inhibitors: Diabetes and CKD and CHF (and gout?), oh my!
What mechanisms might account for the diverse beneficial effects of the SGLT-2 inhibitors observed across various diseases?
- Preventing herpes zoster in immunocompromised patients: Current concepts
The authors review clinical aspects of herpes zoster vaccination, including identifying at-risk patients, weighing the risks and benefits of the recombinant zoster vaccine, and using best practices for administering the vaccine.
- Does my patient with acute variceal hemorrhage need a transjugular intrahepatic portosystemic shunt?
Placement of a transjugular intrahepatic portosystemic shunt can be used as salvage therapy to control bleeding when endoscopic management fails and as a means of secondary prophylaxis in select patients.

